Atlas Trials

Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease

Clinical trial NCT02388152 · TERMINATED

Trial details

NCT number
NCT02388152
Sponsor
H. Lundbeck A/S
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2015-03-01
Primary completion
2019-07-04
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.